Newsbenzinga
Sanofi CEO Belen Garijo Says Beyond 2030, Expect Total Revenues To Be Impacted Only Moderately By Dupixent's Loss Of Exclusivity
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…